These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 19799986)
21. A novel tetramethylpyrazine bis-nitrone (TN-2) protects against 6-hydroxyldopamine-induced neurotoxicity via modulation of the NF-κB and the PKCα/PI3-K/Akt pathways. Xu DP; Zhang K; Zhang ZJ; Sun YW; Guo BJ; Wang YQ; Hoi PM; Han YF; Lee SM Neurochem Int; 2014 Dec; 78():76-85. PubMed ID: 25217805 [TBL] [Abstract][Full Text] [Related]
22. Martins IK; de Carvalho NR; Macedo GE; Rodrigues NR; Ziech CC; Vinadé L; Filho VMB; Menezes IA; Franco J; Posser T Oxid Med Cell Longev; 2018; 2018():2131895. PubMed ID: 30510616 [TBL] [Abstract][Full Text] [Related]
23. Ginsenoside Rg1 promotes nonamyloidgenic cleavage of APP via estrogen receptor signaling to MAPK/ERK and PI3K/Akt. Shi C; Zheng DD; Fang L; Wu F; Kwong WH; Xu J Biochim Biophys Acta; 2012 Apr; 1820(4):453-60. PubMed ID: 22178929 [TBL] [Abstract][Full Text] [Related]
24. Neuroprotective effects of luteolin against apoptosis induced by 6-hydroxydopamine on rat pheochromocytoma PC12 cells. Guo DJ; Li F; Yu PH; Chan SW Pharm Biol; 2013 Feb; 51(2):190-6. PubMed ID: 23035972 [TBL] [Abstract][Full Text] [Related]
25. [The protective effect of ginsenoside Rg1 on dopaminergic neurons of substantia in the ovariectomized rat model of Parkinson's disease]. Xu L; Liu LX; Chen WF; Xie JX; Huang WX Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2008 Feb; 24(1):1-5. PubMed ID: 21141541 [TBL] [Abstract][Full Text] [Related]
26. Involvement of IGF-I receptor and estrogen receptor pathways in the protective effects of ginsenoside Rg1 against Aβ₂₅₋₃₅-induced toxicity in PC12 cells. Chen WF; Zhou LP; Chen L; Wu L; Gao QG; Wong MS Neurochem Int; 2013 Jun; 62(8):1065-71. PubMed ID: 23603302 [TBL] [Abstract][Full Text] [Related]
27. 7,8-dihydroxyflavone protects PC12 cells against 6-hydroxydopamine-induced cell death through modulating PI3K/Akt and JNK pathways. Han XH; Cheng MN; Chen L; Fang H; Wang LJ; Li XT; Qu ZQ Neurosci Lett; 2014 Oct; 581():85-8. PubMed ID: 25139527 [TBL] [Abstract][Full Text] [Related]
28. Ginsenoside Rg1 promotes cerebral angiogenesis via the PI3K/Akt/mTOR signaling pathway in ischemic mice. Chen J; Zhang X; Liu X; Zhang C; Shang W; Xue J; Chen R; Xing Y; Song D; Xu R Eur J Pharmacol; 2019 Aug; 856():172418. PubMed ID: 31132356 [TBL] [Abstract][Full Text] [Related]
29. Pigment epithelium-derived factor (PEDF) protects cortical neurons in vitro from oxidant injury by activation of extracellular signal-regulated kinase (ERK) 1/2 and induction of Bcl-2. Sanchez A; Tripathy D; Yin X; Luo J; Martinez J; Grammas P Neurosci Res; 2012 Jan; 72(1):1-8. PubMed ID: 21946416 [TBL] [Abstract][Full Text] [Related]
30. IGF-I receptor signaling pathway is involved in the neuroprotective effect of genistein in the neuroblastoma SK-N-SH cells. Gao QG; Xie JX; Wong MS; Chen WF Eur J Pharmacol; 2012 Feb; 677(1-3):39-46. PubMed ID: 22227334 [TBL] [Abstract][Full Text] [Related]
31. Protein kinase C delta mediated cytotoxicity of 6-Hydroxydopamine via sustained extracellular signal-regulated kinase 1/2 activation in PC12 cells. Fan Y; Li J; Zhang YQ; Jiang LH; Zhang YN; Yan CQ Neurol Res; 2014 Jan; 36(1):53-64. PubMed ID: 24107416 [TBL] [Abstract][Full Text] [Related]
32. Involvement of K(ATP)/PI (3)K/AKT/Bcl-2 pathway in hydrogen sulfide-induced neuroprotection against the toxicity of 1-methy-4-phenylpyridinium ion. Tang XQ; Zhuang YY; Fan LL; Fang HR; Zhou CF; Zhang P; Hu B J Mol Neurosci; 2012 Feb; 46(2):442-9. PubMed ID: 21800153 [TBL] [Abstract][Full Text] [Related]
33. Ginsenoside Rg1 protects primary cultured rat hippocampal neurons from cell apoptosis induced by β-amyloid protein. Gong L; Li SL; Li H; Zhang L Pharm Biol; 2011 May; 49(5):501-7. PubMed ID: 21438847 [TBL] [Abstract][Full Text] [Related]
34. Protective effect of hydrogen sulphide against 6-OHDA-induced cell injury in SH-SY5Y cells involves PKC/PI3K/Akt pathway. Tiong CX; Lu M; Bian JS Br J Pharmacol; 2010 Sep; 161(2):467-80. PubMed ID: 20735429 [TBL] [Abstract][Full Text] [Related]
35. Resistin protects against 6-hydroxydopamine-induced cell death in dopaminergic-like MES23.5 cells. Lu DY; Chen JH; Tan TW; Huang CY; Yeh WL; Hsu HC J Cell Physiol; 2013 Mar; 228(3):563-71. PubMed ID: 22806254 [TBL] [Abstract][Full Text] [Related]
36. Ginsenoside Rg1 attenuates tau phosphorylation in SK-N-SH induced by Aβ-stimulated THP-1 supernatant and the involvement of p38 pathway activation. Li W; Chu Y; Zhang L; Yin L; Li L Life Sci; 2012 Oct; 91(15-16):809-15. PubMed ID: 22982182 [TBL] [Abstract][Full Text] [Related]
37. Pyruvate protects cerebellar granular cells from 6-hydroxydopamine-induced cytotoxicity by activating the Akt signaling pathway and increasing glutathione peroxidase expression. Fernandez-Gomez FJ; Pastor MD; Garcia-Martinez EM; Melero-Fernandez de Mera R; Gou-Fabregas M; Gomez-Lazaro M; Calvo S; Soler RM; Galindo MF; Jordán J Neurobiol Dis; 2006 Nov; 24(2):296-307. PubMed ID: 16978869 [TBL] [Abstract][Full Text] [Related]
38. Targeted antitumor activity of Ginsenoside (Rg1) in paclitaxel-resistant human nasopharyngeal cancer cells are mediated through activation of autophagic cell death, cell apoptosis, endogenous ROS production, S phase cell cycle arrest and inhibition of m-TOR/PI3K/AKT signalling pathway. Li W; Li G; She W; Hu X; Wu X J BUON; 2019; 24(5):2056-2061. PubMed ID: 31786875 [TBL] [Abstract][Full Text] [Related]
39. Ginsenoside Rg1 protects cardiomyocytes from hypoxia-induced injury through the PI3K/AKT/mTOR pathway. Qin L; Fan S; Jia R; Liu Y Pharmazie; 2018 Jun; 73(6):349-355. PubMed ID: 29880088 [TBL] [Abstract][Full Text] [Related]
40. Glucocorticoid receptor is involved in the neuroprotective effect of ginsenoside Rg1 against inflammation-induced dopaminergic neuronal degeneration in substantia nigra. Sun XC; Ren XF; Chen L; Gao XQ; Xie JX; Chen WF J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):94-103. PubMed ID: 26455404 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]